Nestle Acquires Core Brands of The Bountiful Company for $5.75B

Updated on May 3, 2021 at 8:11 am UTC by · 3 mins read

Nestle expects to finalize the acquisition of The Bountiful Company during the second half of this year. 

Nestle SA (Swiss Exchange: NES.N-CH) announced on Friday that it has acquired core brands of The Bountiful Company for USD 5.75 billion. As part of the acquisition, Nestle noted that the transaction will include high-growth brands Nature’s Bounty, Solgar, Osteo Bi-Flex, Puritan’s Pride as well as the company’s US private label business.

The Bountiful Company is well known as a manufacturer, marketer, and seller of vitamins, minerals, herbal, and other active nutrition products. On the other hand, Nestle is a Swiss multinational food and drink processing that has thrived in most global markets and also decades. Notably, the acquisition is strategic for the company as they are both focused on similar products.

Nestle and The Bountiful Company Market Outlook

According to a press release, Nestle expects to finalize the acquisition of The Bountiful Company during the second half of the year, 2021. However, the company’s segments that do not complement Nestle’s business will not be included in the deal. Some of the segments include sports and active nutrition brands Pure Protein, Body Fortress among others.

The acquired brands reported sales of approximately $1.87 billion during the first quarter. Nestle acquired the Bountiful Company on a debt-free basis representing a multiple of 3.1x net sales and 16.8x EBITDA as of March 31, 2021. The partnership is expected to yield positive results after both companies harmonize their expertise, estimated in 2024.

“Vitamins and supplements are a key part of our business and have contributed to strong growth acceleration,” said Nestlé Health Science CEO Greg Behar. “This acquisition complements our existing health and nutrition portfolio in terms of brands and channels. It will establish Nestlé Health Science as the industry leader in mass retail, specialty retail, e-commerce, and direct-to-consumer in the US while offering significant opportunities for geographic growth.”

The Bountiful Company is expected to operate independently but partner with the parent company in developing its products.

“Today’s announcement from Nestlé Health Science recognizes the transformation of The Bountiful Company over the past 3+ years, as well as the collective value and capability of the organization. I am incredibly grateful to the more than 4,500 colleagues around the globe who have worked tirelessly to get us to this point,” said Paul Sturman, President, and CEO, The Bountiful Company. “As a leader in global nutrition, we take seriously our responsibility and role in consumers’ health and wellness. We’re incredibly proud of the trusted brands we’ve built and are confident that they will be strong assets for Nestlé.”

According to market data provided by CNBC, Nestle stock was trading around CHF 109.24, up approximately 0.07%. The stocks are up approximately 4.57% year-to-date.

Share:

Related Articles

Total Crypto Market Cap Hits New ATH Close to $2.3T, Bitcoin Breaks Resistance Price to Near $59K

By May 3rd, 2021

The overall value of the crypto market makes it $100 billion more valuable than Apple. The $1.1 trillion value of Bitcoin puts it ahead of the likes of other heavyweight companies including Tesla and Facebook. 

Nestle Records Q1 Sales Increase, Stock Is Slightly Up

By April 22nd, 2021

Currently, shares of Nestle have risen above 2% in the year. It is outshining the European food sector by 3.2%.

Nestle to Acquire Aimmune, Food Allergy Drug Maker, for $2.6 Billion

By August 31st, 2020

Nestle S.A. has secured a $2.6 billion acquisition deal with Aimmune (AIMT). Starting with Aimmune’s Palforzia, Nestle hope to expand its food allergy portfolio.

Exit mobile version